Skip to main content
FDA grants breakthrough status to Reflow's PAD treatment system
1/13/2020

The FDA has granted Reflow Medical breakthrough device designation for its Temporary Spur Stent system for use in below-the-knee peripheral artery disease treatment. The company eyes continued development of the device in other clinical areas and plans to expand on clinical evidence for the system.

Full Story: